№ lp_1_09428
File format: docx
Character count: 5669
File size: 133 KB
Year:
2023
Region / city:
European Union
Topic:
Pharmaceutical technology development
Document type:
Briefing document
Organization:
European Medicines Agency
Author:
Not specified
Target audience:
Pharmaceutical experts, regulatory authorities
Period of validity:
Not specified
Approval date:
Not specified
Date of modifications:
Not specified
This document is a briefing source for discussing pharmaceutical technology and regulatory aspects at a QIG 1:
1 meeting.
Price: 8 / 10 USD
The file will be delivered to the email address provided at checkout within 12 hours.
The file will be delivered to the email address provided at checkout within 12 hours.
Don’t have cryptocurrency yet?
You can still complete your purchase in a few minutes:- Buy Crypto in a trusted app (Coinbase, Kraken, Cash App or any similar service).
- In the app, tap Send.
- Select network, paste our wallet address.
- Send the exact amount shown above.
The final amount may vary slightly depending on the payment method.
The file will be sent to the email address provided at checkout within 24 hours.
The product description is provided for reference. Actual content and formatting may differ slightly.
Organisation:
Wrightington, Wigan and Leigh Teaching Hospitals NHS Foundation Trust
Type of document:
Early market engagement briefing
Sector:
Healthcare
Specialty:
Orthopaedics
Geographic scope:
North West England
Location:
Wrightington Hospital, Wigan
Year:
2024
Purpose:
Exploration of partnership opportunities for private orthopaedic patient services
Partnership model:
Strategic multi-phase public–private partnership
Current private provision:
John Charnley Wing
Private patient income:
£6.6 million (2024/25)
Strategic framework:
Wrightington Strategy 2023–2030
Regulatory context:
NHS Foundation Trust
Market focus:
UK private orthopaedic healthcare market
Target partners:
Experienced private healthcare providers
Source type:
Institutional briefing and market engagement material
Year:
2022
Region / City:
RBKC
Subject:
Asset Management, Housing Maintenance
Document Type:
Tender Briefing
Organization:
RBKC Housing Management
Author:
Not specified
Target Audience:
Service Providers
Period of Validity:
Not specified
Approval Date:
May 2022
Date of Revisions:
Not specified
Year:
2025
Region / City:
Brooklyn
Topic:
SAS, Visual Analytics, Skills Transfer
Document Type:
Request for Proposal (RFP)
Organization:
SARS
Author:
SARS
Target Audience:
Service Providers, SAS Experts
Period of Validity:
12 months
Approval Date:
Not specified
Amendment Date:
Not specified
Year:
2025
Region / City:
Bath, UK
Subject:
Foreign Influence Registration Scheme
Document Type:
Briefing Note
Institution:
University of Bath
Author:
Unknown
Target Audience:
University staff and students
Effective Period:
From 1 July 2025
Approval Date:
Unknown
Date of Amendments:
Unknown
Year:
2025
Region / City:
Scotland
Topic:
Creative Industries
Document Type:
Sector Report
Organization:
Office of the Chief Economic Adviser
Author:
N/A
Target Audience:
Policymakers, Economists, Business Analysts
Period of Validity:
2025
Approval Date:
11 December 2025
Date of Changes:
N/A
Year:
2025
Region / country:
Global
Theme:
Land acquisition for biodiversity conservation
Document type:
Project proposal briefing
Organization:
IUCN NL
Author:
IUCN NL
Target audience:
Local NGOs, CSOs, environmental conservation organizations
Period of validity:
Until 2025
Date of approval:
Not specified
Date of changes:
Not specified
Year:
2024
Region / City:
United Kingdom
Topic:
Pharmacy Education, Workforce Wellbeing, Leadership Development
Document Type:
Briefing
Institution:
School of Pharmacy and Medicines Optimisation
Author:
Unknown
Target Audience:
Pharmacists, Pharmacy Technicians, Healthcare Scientists, ICB leads, Employers
Period of Validity:
November 2024
Approval Date:
November 2024
Change Date:
None
Year:
2026
Document Type:
Regulatory submission packet
Target Audience:
FDA reviewers, clinical researchers
Scope:
Preclinical and clinical development planning
Therapeutic Area:
Pharmacology / Drug development
Contents:
Introduction, Clinical Background, Regulatory Background, Pharmacology, Clinical Plan, Toxicology, Chemistry, Manufacturing and Controls, Development Plans, FDA Questions, References
Note:
Year
Year:
2024
Organization:
School of Pharmacy and Medicines Optimisation, NHS England
Document type:
Briefing / Newsletter
Target audience:
Trainee pharmacists, pharmacy technicians, independent prescribers, community pharmacy leads
Topics:
Apprenticeships, National Education and Training Survey, independent prescribing supervision, community pharmacy workforce
Period:
October 2024
Key dates:
EOI closing 13 October 2024, NETS survey open until 26 November 2024
Funding:
£15,053 per trainee per year for Community Pharmacy Technician Apprenticeship Programme
Year:
2024
Region / City:
United Kingdom
Subject:
Pharmacy education and workforce development
Document type:
Informational briefing
Organization / Institution:
NHS England
Author:
School of Pharmacy and Medicines Optimisation
Target audience:
Pharmacy professionals, NHS managers, apprentices
Effective period:
September 2024 - ongoing
Approval date:
September 2024
Date of updates:
September 2024
Year:
2024
Region / City:
Scotland
Topic:
National Care Service, healthcare, social care
Document Type:
Briefing
Organization / Institution:
The Health and Social Care Alliance Scotland (the ALLIANCE)
Author:
Not specified
Target Audience:
Not specified
Period of Validity:
Not specified
Approval Date:
Not specified
Amendment Date:
Not specified
Appendix 2 Version 2 of Passes Policy Guidelines: Briefing for Security Passes and Permit Applicants
Reference:
KAA/9/50/20 VOL. 34
Document type:
Policy guideline appendix
Subject:
Airport security passes and access permits
Regulatory basis:
KCASRs, 2020 Regulation 62
Issuing authority:
Issuing Authority
Sector:
Aviation security
Geographic scope:
Airport restricted and landside areas
Conditions of use:
Display, access limitations, surrender, and loss reporting
Penalties:
Fine up to KES 500,000, imprisonment up to six months, or both
Applicable personnel:
Airport employees, contractors, visitors, and permit holders
Includes declaration:
Yes
Year:
2020
Region / City:
Denver
Theme:
Environmental Regulation
Document Type:
Briefing Paper
Agency:
National Park Service (NPS) - Denver Service Center (DSC)
Author:
Unknown
Target Audience:
Federal development project planners, environmental compliance officers
Effective Period:
Ongoing
Approval Date:
04-10-2020
Amendment Date:
N/A
Note:
Incident Name
Context description:
A document used for incident briefing within the Incident Command System (ICS), outlining essential information such as objectives, actions, safety measures, and resource management.
Year:
2023
Region / city:
Australia
Subject:
Pharmaceutical compounding guidelines
Document Type:
Guideline
Organization / Institution:
Pharmacy Board of Australia
Author:
Pharmacy Board of Australia
Target Audience:
Registered pharmacists, education providers, employers
Period of validity:
Indefinite
Approval Date:
Not specified
Date of amendments:
Not specified
Year:
2016
Region / City:
Australia
Topic:
Pharmacy, Medicine Compounding
Document Type:
Consultation Response
Organization:
Pharmaceutical Society of Australia
Author:
Dr Lance Emerson, Chief Executive Officer
Target Audience:
Pharmacists, Pharmacy Regulators
Period of Validity:
Indefinite
Approval Date:
1 February 2016
Date of Amendments:
None
Contextual Description:
Document is a public consultation response discussing terminology issues and proposed updates regarding compounded parenteral medicines, primarily aimed at Australian pharmacists.
Organisation:
Canberra Health Services
Document type:
Guideline
Reference number:
CHS25/225
Jurisdiction:
Australian Capital Territory
Healthcare setting:
Public health services
Subject area:
Medication management
Professional scope:
Nursing and midwifery practice
Approved by:
Drug and Therapeutics Committee
Target professionals:
Registered nurses and registered midwives
Patient groups:
Adults, children 12 years or older, and selected medicines for children under 12 years
Exclusions:
Neonates, Special Care Nursery patients, Neonatal Intensive Care Unit patients
Regulatory framework:
Australian medicines scheduling (Schedules 2, 3, 4, and 8)
Content components:
Governance, safe use, documentation, approved medicine lists
Year:
2023
Country:
Australia
Topic:
Opioid dependence treatment
Document type:
Information overview
Program:
ODT Community Pharmacy Program
Administering body:
Pharmacy Programs Administrator
Related scheme:
Pharmaceutical Benefits Scheme
Legislative framework:
National Health (Highly specialised drugs program) Special Arrangement 2021
Target audience:
Community pharmacists and hospital pharmacists
Effective date:
1 July 2023
Funding period:
2023–24 to 2026–27
Medicines covered:
Methadone, buprenorphine, buprenorphine with naloxone
Regulatory classification:
Schedule 8 controlled drugs
Source type:
Government health program guidance
Document type:
Q&A guidance
Jurisdiction:
Japan
Subject:
Import and shipment of medicines and medical devices
Issuing authority:
Ministry of Health, Labour and Welfare
Intended users:
Individuals importing or sending medicines for personal use
Scope:
Prescription medicines, injections, syringes, and medical devices
Import purpose:
Personal use
Regulatory framework:
Pharmaceutical and Medical Device regulations
Application system:
Online Import Confirmation system
Related forms:
Import Confirmation Application Form (Form 12); Explanation of Pharmaceutical Product (Form 13)